Wealthspring Capital’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
2022
Q4
$180K Sell
2022
Q3
$1.93M Sell
2022
Q2
$1.96M Sell
2022
Q1
$2.07M Sell
2021
Q4
$2.32M Sell
2021
Q3
$2.5M Sell
2021
Q2
$2.79M Sell
2021
Q1
$2.89M Buy